Nov 21, 2017 13:38 pm UTC| Business
LONDON, Nov. 21, 2017 -- The global healthcare/medical simulation market will grow at a CAGR of 15.0% from 2017 to 2022 to reach USD $2,281.0 million by 2022, according to the latest publication from Meticulous...
Nov 21, 2017 13:33 pm UTC| Business
LAS VEGAS, Nov. 21, 2017 -- The latest trending report published by Crystal Market Research titled, Organic Personal Care Market, approximates that the Organic Personal Care Market size is estimated to flourish at a...
Nov 21, 2017 13:32 pm UTC| Business
Lausanne, Switzerland, November 21, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will host...
Modex adds top advisor from Google
Nov 21, 2017 13:31 pm UTC| Business
LONDON, Nov. 21, 2017 -- Modex (www.Modex.tech), the smart contract marketplace, announces the signing of Google executive as its latest advisor. Onur Bildik, a Google seasoned business professional, advises large...
Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%
Nov 21, 2017 13:31 pm UTC| Business
BUENA, N.J., Nov. 21, 2017 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA)...
AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017 at 7:30 a.m.
Nov 21, 2017 13:31 pm UTC| Business
Will present data from its NO-NTM Phase 2 clinical trial for patients suffering from Nontuberculous Mycobacteria (NTM) Abscessus NEW YORK, Nov. 21, 2017 -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage...
Nov 21, 2017 13:31 pm UTC| Business
VANCOUVER, British Columbia, Nov. 21, 2017 -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases,...